Renaissance Technologies - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 190 filers reported holding IMMUNOGEN INC in Q2 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$11,659
-49.3%
734,640
-39.7%
0.02%
-39.4%
Q2 2023$22,984
+7460.5%
1,218,040
+1439.1%
0.03%
Q1 2023$304
-100.0%
79,140
-95.4%
0.00%
-100.0%
Q3 2022$8,151,000
+25.0%
1,705,140
+17.7%
0.01%
+50.0%
Q2 2022$6,519,000
-6.3%
1,448,740
-0.9%
0.01%0.0%
Q1 2022$6,961,000
-22.9%
1,462,340
+20.1%
0.01%
-27.3%
Q4 2021$9,033,000
+39.5%
1,217,387
+6.6%
0.01%
+37.5%
Q3 2021$6,474,000
-52.9%
1,141,840
-45.2%
0.01%
-52.9%
Q2 2021$13,734,000
-9.0%
2,084,090
+11.8%
0.02%
-10.5%
Q1 2021$15,093,000
-44.8%
1,863,340
-56.0%
0.02%
-36.7%
Q4 2020$27,322,000
+17.0%
4,235,966
-34.7%
0.03%
+30.4%
Q3 2020$23,361,000
-47.5%
6,489,139
-32.9%
0.02%
-39.5%
Q2 2020$44,460,000
+18.4%
9,665,139
-12.3%
0.04%
+5.6%
Q1 2020$37,565,000
-31.3%
11,016,129
+2.9%
0.04%
-14.3%
Q4 2019$54,660,000
+165.0%
10,707,139
+25.6%
0.04%
+147.1%
Q3 2019$20,626,000
+37.3%
8,523,039
+23.1%
0.02%
+30.8%
Q2 2019$15,022,000
-21.3%
6,922,640
-1.7%
0.01%
-23.5%
Q1 2019$19,088,000
-35.7%
7,043,640
+13.9%
0.02%
-46.9%
Q4 2018$29,674,000
-50.4%
6,182,140
-2.1%
0.03%
-47.5%
Q3 2018$59,781,000
-47.6%
6,312,640
-44.3%
0.06%
-1.6%
Q2 2018$114,049,000
+125.6%
11,331,240
+135.8%
0.06%
+12.7%
Q1 2018$50,558,000
+621.4%
4,805,940
+339.6%
0.06%
+587.5%
Q4 2017$7,008,000
+74.7%
1,093,240
+108.5%
0.01%
+60.0%
Q3 2017$4,011,000
-21.9%
524,340
-27.4%
0.01%
-28.6%
Q2 2017$5,136,000
-10.2%
722,340
-51.1%
0.01%
-12.5%
Q1 2017$5,720,000
+13.0%
1,477,946
-40.4%
0.01%0.0%
Q4 2016$5,063,000
-24.5%
2,481,740
-0.9%
0.01%
-33.3%
Q3 2016$6,709,000
+10.7%
2,503,340
+27.3%
0.01%0.0%
Q2 2016$6,059,000
+1074.2%
1,967,140
+5071.2%
0.01%
+1100.0%
Q4 2015$516,000
-86.3%
38,040
-90.3%
0.00%
-88.9%
Q3 2015$3,777,000
+280.4%
393,440
+141.6%
0.01%
+350.0%
Q4 2014$993,000
-74.7%
162,840
-56.0%
0.00%
-81.8%
Q3 2014$3,923,000
-20.3%
370,446
-10.8%
0.01%0.0%
Q2 2014$4,923,000415,4400.01%
Other shareholders
IMMUNOGEN INC shareholders Q2 2020
NameSharesValueWeighting ↓
Redmile Group, LLC 17,503,417$277,779,22813.22%
Fairmount Funds Management LLC 5,929,592$94,102,62511.32%
CM Management, LLC 500,000$7,935,0008.42%
SILVERARC CAPITAL MANAGEMENT, LLC 1,307,435$20,748,9936.29%
Altium Capital Management LP 725,000$11,505,7506.00%
RA Capital Management 13,322,288$211,424,7114.16%
TANG CAPITAL MANAGEMENT LLC 1,500,000$23,805,0003.36%
BRIDGER MANAGEMENT, LLC 467,220$7,414,7812.73%
Birchview Capital, LP 190,000$3,015,3002.57%
Boxer Capital, LLC 2,961,000$46,991,0702.50%
View complete list of IMMUNOGEN INC shareholders